Virax Total Assets from 2010 to 2024

VRAX Stock

USD 1.97 0.10 4.83%

Virax Biolabs Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets will likely drop to about 3.4 M in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2010-12-31

Previous Quarter

5.5 M

Current Value

3.4 M

Quarterly Volatility

2.8 M

Credit Downgrade

Yuan Drop

Covid

Check Virax Biolabs financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Virax Biolabs' main balance sheet or income statement drivers, such as Tax Provision of 0.0, Depreciation And Amortization of 97.9 K or Interest Expense of 28.3 K, as well as many indicators such as Price To Sales Ratio of 8.96, Dividend Yield of 0.0 or PTB Ratio of 0.29. Virax financial statements analysis is a perfect complement when working with Virax Biolabs Valuation or Volatility modules.

Check out the analysis of Virax Biolabs Correlation against competitors.

Latest Virax Biolabs' Total Assets Growth Pattern

Below is the plot of the Total Assets of Virax Biolabs Group over the last few years. Total assets refers to the total amount of Virax Biolabs assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Virax Biolabs Group books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Virax Biolabs' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Virax Biolabs' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 5.48 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Virax Total Assets Regression Statistics

	Arithmetic Mean	1,271,127
	Geometric Mean	79,027
	Coefficient Of Variation	224.20
	Mean Deviation	1,984,614
	Median	22,609
	Standard Deviation	2,849,915
	Sample Variance	8.1T
	Range	9.8M
	R-Value	0.59
	Mean Square Error	5.7T
	R-Squared	0.35
	Significance	0.02
	Slope	377,461
	Total Sum of Squares	113.7T

Virax Total Assets History

	2024	3.4 M
	2023	5.5 M
	2022	9.8 M
	2021	48.7 K
	2020	94.1 K

Other Fundumenentals of Virax Biolabs Group

Intangibles To Total Assets

Virax Biolabs Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Net Invested Capital	Total Current Assets	Capital Stock	Net Working Capital	Short Term Debt	Common Stock	Short Term Investments	Short Long Term Debt	Intangible Assets
Total Assets		0.97	0.86	0.7	-0.98	-0.76	-0.32	-0.63	0.97	1.0	0.73	1.0	-0.62	0.73	0.85	-0.38	-0.47
Total Stockholder Equity	0.97		0.95	0.77	-0.97	-0.86	-0.37	-0.77	1.0	0.96	0.85	0.97	-0.69	0.85	0.9	-0.58	-0.6
Net Tangible Assets	0.86	0.95		0.78	-0.85	-0.97	-0.43	-0.91	0.95	0.83	0.95	0.86	-0.72	0.95	0.96	-0.79	-0.81
Current Deferred Revenue	0.7	0.77	0.78		-0.74	-0.81	0.12	-0.78	0.76	0.68	0.86	0.7	-0.99	0.86	0.74	-0.57	-0.6
Net Debt	-0.98	-0.97	-0.85	-0.74		0.74	0.25	0.62	-0.97	-0.99	-0.73	-0.99	0.66	-0.73	-0.79	0.4	0.41
Retained Earnings	-0.76	-0.86	-0.97	-0.81	0.74		0.33	0.94	-0.86	-0.71	-0.99	-0.75	0.77	-0.99	-0.96	0.85	0.9
Accounts Payable	-0.32	-0.37	-0.43	0.12	0.25	0.33		0.45	-0.37	-0.3	-0.21	-0.32	-0.18	-0.21	-0.42	0.39	0.41
Total Liab	-0.63	-0.77	-0.91	-0.78	0.62	0.94	0.45		-0.76	-0.58	-0.92	-0.63	0.76	-0.92	-0.89	0.88	0.91
Net Invested Capital	0.97	1.0	0.95	0.76	-0.97	-0.86	-0.37	-0.76		0.96	0.84	0.97	-0.69	0.84	0.89	-0.58	-0.59
Total Current Assets	1.0	0.96	0.83	0.68	-0.99	-0.71	-0.3	-0.58	0.96		0.69	1.0	-0.59	0.69	0.8	-0.34	-0.4
Capital Stock	0.73	0.85	0.95	0.86	-0.73	-0.99	-0.21	-0.92	0.84	0.69		0.73	-0.83	1.0	0.93	-0.85	-0.87
Net Working Capital	1.0	0.97	0.86	0.7	-0.99	-0.75	-0.32	-0.63	0.97	1.0	0.73		-0.62	0.73	0.84	-0.37	-0.46
Short Term Debt	-0.62	-0.69	-0.72	-0.99	0.66	0.77	-0.18	0.76	-0.69	-0.59	-0.83	-0.62		-0.83	-0.69	0.56	0.58
Common Stock	0.73	0.85	0.95	0.86	-0.73	-0.99	-0.21	-0.92	0.84	0.69	1.0	0.73	-0.83		0.93	-0.85	-0.87
Short Term Investments	0.85	0.9	0.96	0.74	-0.79	-0.96	-0.42	-0.89	0.89	0.8	0.93	0.84	-0.69	0.93		-0.71	-0.87
Short Long Term Debt	-0.38	-0.58	-0.79	-0.57	0.4	0.85	0.39	0.88	-0.58	-0.34	-0.85	-0.37	0.56	-0.85	-0.71		0.85
Intangible Assets	-0.47	-0.6	-0.81	-0.6	0.41	0.9	0.41	0.91	-0.59	-0.4	-0.87	-0.46	0.58	-0.87	-0.87	0.85

Click cells to compare fundamentals

About Virax Biolabs Financial Statements

Virax Biolabs investors use historical fundamental indicators, such as Virax Biolabs' Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Virax Biolabs. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Total Assets	5.5 M	3.4 M
Intangibles To Total Assets	0.01	0.02

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for Virax Stock Analysis

When running Virax Biolabs' price analysis, check to measure Virax Biolabs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Virax Biolabs is operating at the current time. Most of Virax Biolabs' value examination focuses on studying past and present price action to predict the probability of Virax Biolabs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Virax Biolabs' price. Additionally, you may evaluate how the addition of Virax Biolabs to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC